Levitate Bio’s CEO Sam DeLuca, left, and Karen Khar, executive vice president of sales and business development. (LinkedIn Photos) Seattle startup Cyrus Biotechnology is spinning out a business that ...
16don MSN
My Top 3 Biotech Stocks for May 2026
As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies are beginning to stand out from the crowd.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results